Funding will accelerate development of the company’s AI-powered antibody drug discovery technology, focused on identifying new therapeutics for cancer, heart, and lung diseases
Acquisition enables WuXi AppTec to offer its customers end-to-end support in the creation and development of cutting-edge cell and gene therapies for patients in need worldwide
Insilico and Meyer Chroma Technology partner to enable integrated predictive process modeling for process development, manufacturing, and product purification